Clinical Trials Directory

Trials / Completed

CompletedNCT01436903

Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length

Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length, a Questionnaire Investigation on 290 Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
290 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
Female
Age
30 Years – 55 Years
Healthy volunteers
Not accepted

Summary

CavatermTM is a second-generation thermal balloon ablation device in the management of menorrhagia. The purpose of this study is to investigate the success (questionnaire) of CavatermTM dependent on uterus probe length, especially corpus probe length, which is measured during surgery.

Conditions

Interventions

TypeNameDescription
DEVICEThermal Balloon Endometrial AblationThermal Balloon Endometrial Ablation for 10 minutes after curettage

Timeline

Start date
2010-09-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2011-09-20
Last updated
2013-03-08

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01436903. Inclusion in this directory is not an endorsement.

Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length (NCT01436903) · Clinical Trials Directory